Genital or anal ulcer (herpes, syphilis, mpox, lymphogranuloma venereum, chancroid)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Acute ulcer (less than one month)
- Any acute genital ulcer is presumed to be syphilis: presumptive treatment can be given the same day, without waiting for results.
Swab of the base of the lesion (before any local treatment)
- Herpes simplex PCR (HSV-1 and HSV-2) with typing
- Treponema pallidum PCR on the lesion (not in the French laboratory fee schedule)if neededSuggestive chancre, especially during the window when serology is still negative, or oral or anal lesion: PCR is the preferred direct detection method [2]. Not listed in the NABM: specialised laboratory.
- Mpox PCR on the lesionif neededDiagnostic doubt (atypical appearance, undefined context of infection) [3,4]; sample by swabbing several lesions, mucous membranes preferably [3,5].
- Chlamydia trachomatis and gonococcus NAAT (PCR) on the lesion (or first-catch urine), with L genotyping if positiveif neededSuspected lymphogranuloma venereum: large inflammatory inguinal lymph node, anorectitis, man who has sex with men [6,7]. State “L genotyping requested”: it is done at the clinician’s request on a positive PCR [6].
- Haemophilus ducreyi PCR (chancroid, not in the French laboratory fee schedule)if neededContact in an endemic area (Africa, South-East Asia, South America) [8]: nucleic acid amplification can demonstrate the bacterium [9].
Laboratory tests
- Syphilis serology (treponemal test, then titrated non-treponemal test by the laboratory)
- HIV serology
- Hepatitis B serologyif neededTest for all other STIs [8]; the HAS specified this for mpox (HIV, HBV, HCV, syphilis, Chlamydia and gonococcus) [4].
- Hepatitis C serologyif neededTest for all other STIs [8]; the HAS specified this for mpox (HIV, HBV, HCV, syphilis, Chlamydia and gonococcus) [4].
- Chlamydia and gonococcus NAAT (PCR) on first-catch urine or self-collected sample (screening for associated STIs)if neededIf not already done on the lesion: all other STIs are to be tested for [8,10].
Repeat if the initial syphilis serology is negative
- Repeat syphilis serologyif needednon-French guidelineRecent chancre: treponemal test and non-treponemal test are negative before the chancre and during its first 5 to 15 days [2]. See the page “Positive syphilis serology”.
Also consider
- Positive syphilis serology? For interpretation and follow-up, see the page “Positive syphilis serology”.
Do not order
- Herpes serology to diagnose an ulceration: diagnosis rests on PCR of the lesion [10]; the NABM covers serology only before immunosuppressive treatment and at a first episode of genital herpes during pregnancy [3]. Herpes IgM: not recommended [10].
- Haemophilus ducreyi serology: of no value for diagnosing chancroid [9].
- Chlamydia serology in place of PCR for lymphogranuloma: insufficient sensitivity and specificity, non-standardised interpretation [7]; the HAS considers it useless except in upper genital tract infection with no sample available [6].
- Mpox PCR in a person without symptoms [4].
- Mpox serology, rapid test or antigen test: none is validated; laboratory diagnosis rests on PCR of the lesions [4].
- Herpes PCR on a swab in a person without lesions: not recommended, viral shedding being intermittent [10].
Chronic (more than one month) or recurrent ulcer
Swab of the lesion
- Herpes simplex PCR (HSV-1 and HSV-2) with typing
Laboratory tests
- HIV serology
- Syphilis serology (if not done for this episode)if neededThe American CDC (2021) includes it in the assessment of any genital, anal or perianal ulceration [11], and so does the Australian ASHM [14]. The SFD (French Society of Dermatology) asks for all other STIs to be tested for without naming it in the work-up of a chronic ulceration [8].
- FBC
- Type-specific herpes serology (HSV-1, HSV-2) if PCR is negativeif neededRecurrent or atypical lesions with negative PCR: anti-HSV-2 antibodies support the diagnosis of genital herpes [8,10].
- Biopsy of the lesion (with immunofluorescence if bullous dermatosis suspected): to be planned, not a laboratory test.
Do not order
- Non-type-specific herpes serology: of no value in the management of genital herpes; herpes IgM: not recommended [10].
- Immune work-up for frequent herpes recurrences on suppressive treatment: unnecessary, apart from HIV serology [10].
- Regular laboratory monitoring on suppressive herpes treatment in a patient with no other problem: not recommended [10].
Sources (17)
- Alareeki A, Osman AMM, Khandakji MN, Looker KJ, Harfouche M, Abu-Raddad LJ. Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions. Lancet Reg Health Eur. 2023;30:100558.
- Janier M, Unemo M, Dupin N, Tiplica GS, Potočnik M, Patel R. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2021;35(3):574-88.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 4506 (génome des Herpes simplex 1 et 2), 1744 (anticorps anti-HSV), 5273 (génome du virus monkeypox), 1256-1257 (syphilis), 5301-5302 (Chlamydia et gonocoque), 1307 (sérologie Chlamydia).
- Haute Autorité de santé. Réponse rapide : infection par le virus Monkeypox – prise en charge en médecine de 1er recours. Fiche validée par le Collège le 1er septembre 2022 (communiqué du 5 septembre 2022).
- Agence régionale de santé Nouvelle-Aquitaine. Mpox : informations et recommandations. Page consultée le 11 octobre 2026.
- Haute Autorité de santé, Conseil national du sida et des hépatites virales, ANRS-MIE. Traitement curatif des personnes infectées par Chlamydia trachomatis. Recommandation de bonne pratique, avril 2025.
- de Vries HJC, de Barbeyrac B, de Vrieze NHN, et al. 2019 European guideline on the management of lymphogranuloma venereum. J Eur Acad Dermatol Venereol. 2019;33(10):1821-8.
- Société française de dermatologie, section MST. Recommandations diagnostiques et thérapeutiques pour les maladies sexuellement transmissibles, 2016 : chapitres « Urétrite masculine », « Cervicite muco-purulente », « Ulcération génitale », « Orchi-épididymite » (Ann Dermatol Venereol 2016;143).
- Lautenschlager S, Kemp M, Christensen JJ, Mayans MV, Moi H. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017;28(4):324-9.
- Patel R, Moran B, Clarke E, et al. 2024 European guidelines for the management of genital herpes. J Eur Acad Dermatol Venereol. 2025;39(4):742-58.
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
- Patel R, Green J, Moran B, et al. British Association of Sexual Health and HIV UK national guideline for the management of anogenital herpes, 2024. Int J STD AIDS. 2024 (publication en ligne).
- Kingston M, Apea V, Evans C, et al. BASHH UK guidelines for the management of syphilis 2024. Int J STD AIDS. 2024 (publication en ligne).
- Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Australian STI Management Guidelines for Use in Primary Care : Anogenital ulcers. Consultée le 30 octobre 2026.
- UK Health Security Agency. Mpox: diagnostic testing (gov.uk). Mise à jour du 4 avril 2025.
- Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Australian STI Management Guidelines for Use in Primary Care : Lymphogranuloma venereum. Consultée le 30 octobre 2026.
- US Preventive Services Task Force. Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2023;329(6):502-507.